Submitted by Anonymous (not verified) on 14 September 2023 - 13:49
Opinion/decision on a Paediatric investigation plan (PIP): Dimeric protein comprised of two disulfide-linked monomers, each being a fully human fusion protein consisting of a modified extracellular domain of the human activin receptor type IIA fused to the fragment crystallizable domain of human IgG1 Fc including the hinge region, CH2 and CH3 domains (KER-050), decision type: , therapeutic area: , PIP number: P/0407/2022
Source: